BDBM50101777 (2S)-2-{[(benzyloxy)carbonyl]amino}-3-({5-[2-(carbamimidoylcarbamoyl)ethyl]thiophen-2-yl}formamido)propanoic acid::CHEMBL431724

SMILES NC(=N)NC(=O)CCc1ccc(s1)C(=O)NC[C@H](NC(=O)OCc1ccccc1)C(O)=O

InChI Key InChIKey=BEQYLAVXNLFJGM-AWEZNQCLSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50101777   

TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50101777((2S)-2-{[(benzyloxy)carbonyl]amino}-3-({5-[2-(carb...)
Affinity DataIC50:  837nMAssay Description:Concentration required to reduce binding of Kistrin to Vitronectin receptor (alpha V beta 3) by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50101777((2S)-2-{[(benzyloxy)carbonyl]amino}-3-({5-[2-(carb...)
Affinity DataIC50:  39nMAssay Description:Concentration required to reduce binding of human 293 cell attachment to immobilized vitronectin receptor(Vn/293) by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Aventis Pharma Deutschland

Curated by ChEMBL
LigandPNGBDBM50101777((2S)-2-{[(benzyloxy)carbonyl]amino}-3-({5-[2-(carb...)
Affinity DataIC50:  2.90E+3nMAssay Description:Concentration required to reduce binding of fibrinogen (Fg) to alpha IIb beta3 integrin by 50%More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed